Your browser doesn't support javascript.
loading
Early Experience With Neutralizing Monoclonal Antibody Therapy for COVID-19: Retrospective Cohort Survival Analysis and Descriptive Study.
Jarrett, Mark; Licht, Warren; Bock, Kevin; Brown, Zenobia; Hirsch, Jamie; Coppa, Kevin; Brar, Rajdeep; Bello, Stephen; Nash, Ira.
Afiliação
  • Jarrett M; Donald and Barbara Zucker School of Medicine at Hofstra/Northwell Hofstra University Hempstead, NY United States.
  • Licht W; Donald and Barbara Zucker School of Medicine at Hofstra/Northwell Hofstra University Hempstead, NY United States.
  • Bock K; Donald and Barbara Zucker School of Medicine at Hofstra/Northwell Hofstra University Hempstead, NY United States.
  • Brown Z; Donald and Barbara Zucker School of Medicine at Hofstra/Northwell Hofstra University Hempstead, NY United States.
  • Hirsch J; Donald and Barbara Zucker School of Medicine at Hofstra/Northwell Hofstra University Hempstead, NY United States.
  • Coppa K; Northwell Health New Hyde Park, NY United States.
  • Brar R; Donald and Barbara Zucker School of Medicine at Hofstra/Northwell Hofstra University Hempstead, NY United States.
  • Bello S; Northwell Health New Hyde Park, NY United States.
  • Nash I; Donald and Barbara Zucker School of Medicine at Hofstra/Northwell Hofstra University Hempstead, NY United States.
JMIRx Med ; 2(3): e29638, 2021.
Article em En | MEDLINE | ID: mdl-34606522
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article